MUROMACHI CHEMICALS INC.

4885

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-07-14FY2026

Revenue

78.4100M JPY

YoY +17.9%

Operating Income

7.4100M JPY

YoY +71.9%

Net Income

1.6100M JPY

YoY -32.4%

EPS

40.6JPY

YoY -32.8%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

78.4億円

58.8億円

39.2億円

19.6億円

Rev: 56.8億円Op: 4.4億円NI: 4.6億円

Rev: 62.9億円Op: 3.7億円NI: 2.6億円

Rev: 63.7億円Op: 4.2億円NI: 3.3億円

Rev: 66.5億円Op: 4.3億円NI: 2.4億円

Rev: 78.4億円Op: 7.4億円NI: 1.6億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Achievement

FY2026

Net Income-

Revenue Progress78.400M

Revenue Forecast7700M

Net Income Achieved-

Net Income Forecast-

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan